Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
about
Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitisDiabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London.Dowling oration 1975. Fibrinolysis and vasculitis.Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell typeReaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogenPharmacological enhancement of fibrinolytic activity and 125I-fibrinogen survival.The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis.Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitusA marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.The Northwick Park Heart Study: evidence from the laboratory.Comparison of the effects of ethinyl oestradiol and conjugated equine oestrogens in oophorectomized women.The effect of Arvin on experimental immune arthritis in rabbits.Current therapy of rheumatoid arthritis.Phenoformin as a fibrinolytic drug.Decreased plasma fibrinolysis in patients with rheumatoid arthritis.Methodological study and a recommended technique for determining the euglobulin lysis time.An epidemiological study of the haemostatic and other effects of oral contraceptives.Fibrinolytic studies with biguanide derivatives.Mature coconut water exhibits antidiabetic and antithrombotic potential via L-arginine-nitric oxide pathway in alloxan induced diabetic rats.Plasma lipids and coagulation in patients with arteriosclerotic dementia.
P2860
Q33565749-13D667B3-609B-4282-8913-0C3595F54BF7Q33999832-88FF968A-DE9C-4767-85B7-B69EA4729077Q35228199-04BA21F7-6AFB-453A-B39E-2B9C397C40D2Q36041650-51AEA2DD-A905-421A-96F3-F50B9BEF5E75Q36216545-C9180F6E-D99D-49F8-A2CD-697B2EFED10CQ36550406-333E8CD1-EBD9-4D46-B9EF-639C77FBFF76Q36624101-5B0C4E4D-F401-4870-83FC-A8AA4DC04A00Q36633693-46D7D055-46AE-4344-8BC1-3A4C74A15CF0Q36756073-A1A6BC23-42B7-4A13-A638-F34FC19F42EDQ36811751-84161954-FC0A-40CE-A2FB-59C50D65A6DDQ37170305-A628D8C4-BB5D-4494-935A-C9FC9EBE2330Q38193219-45CDAF1F-1521-4F62-9D54-8E36AC80EF2EQ39932062-216405F9-4ECD-4D03-A097-0B6FDB7A8031Q39942757-DFC4D22E-8B20-400A-A103-2640F08A4386Q39976854-5683771B-5B8B-4D05-B4CE-11ACC5160883Q40345776-371C9E5B-07E6-4F2F-BA55-CB7F774BA059Q41144445-CA90E2DA-E290-4D37-83B9-5DC232F51D3BQ41222826-70E4FA5D-B9ED-441B-B562-5E94F37BBC7FQ43841974-5E64B4CE-7180-4F7C-A5AD-6189895D35B0Q47698309-AA29E619-BD18-476E-A5A0-18DE6617A983Q53439658-C0F0F860-1E90-421E-A2DF-51B06FFBA53CQ55507074-9726A879-335A-4BFA-B736-9191EF9CC37F
P2860
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh
1966年學術文章
@zh-hant
name
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@en
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@nl
type
label
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@en
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@nl
prefLabel
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@en
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@nl
P1433
P1476
Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.
@en
P2093
G R Fearnley
R Chakrabarti
P304
P356
10.1016/S0140-6736(66)90360-6
P407
P577
1966-10-01T00:00:00Z